Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03990233
Title A Trial of BI 765063 Monotherapy and in Combination With BI 754091 in Patients With Advanced Solid Tumours
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors OSE Immunotherapeutics

ovarian cancer

colorectal cancer

stomach cancer

spinal cord lymphoma


lung non-small cell carcinoma

triple-receptor negative breast cancer

renal cell carcinoma

pancreatic cancer

head and neck squamous cell carcinoma

transitional cell carcinoma

Advanced Solid Tumor



Effi-DEM + Ezabenlimab

Age Groups: adult | senior
Covered Countries FRA | BEL

No variant requirements are available.